Koers THC Farmaceuticals, Inc. Other OTC
Aandelen
CBDG
US87243T1007
Drugshandelaren
Omzet 2013 | 21,64K 20,14K | Omzet 2014 | 19,03K 17,72K | Marktkapitalisatie | 9,86 mln. 9,18 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | - 0 | Nettowinst (verlies) 2014 | - 0 | EV/omzet 2013 * | - |
Nettoschuld 2013 | 58,16K 54,14K | Nettoschuld 2014 | 77,06K 71,73K | EV/omzet 2014 | 522 x |
K/w-verhouding 2013 * |
-
| K/w-verhouding 2014 |
-321
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 20,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Grossman
CEO | Chief Executive Officer | - | - |
Gary Henrie
LAW | General Counsel | 70 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Tobias
BRD | Director/Board Member | 73 | - |
Mark Grossman
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,68% | 2,85 mld. | |
-17,86% | 1,24 mld. | |
+47,78% | 505 mln. | |
-21,36% | 394 mln. | |
+37,09% | 177 mln. | |
-4,60% | 90,92 mln. | |
+38,20% | 58,26 mln. |